JP Lotz

Bevacizumab plus chemotherapy continued beyond first progression in patients with metastatic colorectal cancer previously treated with bevacizumab plus chemotherapy: ML18147 study KRAS subgroup findings

Stefan Kubicka, Richard Greil, Thierry André et al. · Annals of Oncology · 2013 · 103 citations · Full text

Medicine, Oncology, Pharmacotherapy +9

Recovery, viability and clinical toxicity of thawed and washed haematopoietic progenitor cells: analysis of 952 autologous peripheral blood stem cell transplantations

Eléna Foïs, M Desmartin, Sonia Benhamida et al. · Bone Marrow Transplantation · 2007 · 61 citations

Medicine, Cell Biology, Hematology +14

Osteosarcomas of the mandible: multidisciplinary management of a rare tumor of the young adult a cooperative study of the GSF-GETO, Rare Cancer Network, GETTEC/REFCOR and SFCE

Juliette Thariat, Thomas Schouman, A. Brouchet et al. · Annals of Oncology · 2012 · 56 citations · Full text

Medicine, Oncology, Surgery +15

Cyclophosphamide/mitoxantrone/melphalan (CMA) regimen prior to autologous bone marrow transplantation (ABMT) in metastatic breast cancer.

Christian Gisselbrecht, J.M. Extra, JP Lotz et al. · PubMed · 1996 · 27 citations

Medicine, Oncology, Pharmacology +14

High-dose chemotherapy followed by reinfusion of selected CD34+ peripheral blood cells in patients with poor-prognosis breast cancer: a randomized multicentre study

Christian Chabannon, Kenneth Cornetta, JP Lotz et al. · British Journal of Cancer · 1998 · 25 citations · Full text

Medicine, Hematology, Oncology +13